Journal of Clinical Endocrinology & Metabolism, Vol 80, 2700-2708, Copyright © 1995 by Endocrine Society

ARTICLES

Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia

RC Baxter, SR Holman, A Corbould, S Stranks, PJ Ho and W Braund
Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney, New South Wales, Australia.

Hypoglycemia in patients with nonislet cell tumors is often secondary to overexpression of tumor insulin-like growth factor (IGF) II. In these patients the formation of serum complexes between IGFs, IGF binding protein-3 (IGFBP-3), and the acid-labile subunit (ALS) is impaired. An 87-yr-old woman with nonislet cell tumor hypoglycemia resulting from a localized fibrous tumor of the pleura was treated for 97 days with graded doses of prednisolone (30, 10, and 5 mg/day) followed by GH (1, 4, 8, 4, and 2 U/day). Both prednisolone and GH alleviated the hypoglycemia, concomitantly with increases in IGF-I, IGFBP-3, and ALS levels. Pretreatment serum IGFBP-2 and IGFBP-6 levels were greatly elevated, but as glucose normalized with treatment, only IGFBP-2 decreased, showing an inverse correlation with glucose (r = 0.716). IGFBP-1 gave a variable pattern not clearly related to blood glucose. Both treatments caused a redistribution of serum IGFBP-3 from binary- to ternary-complexed forms. However, only prednisolone improved the ability of IGFBP-3 to bind ALS in vitro. Prednisolone also suppressed IGF-II, the effect being confined to pro-IGF-II forms. Compared with normal IGF-II, pro-IGF-II inhibited ALS binding to IGFBP- 3 in vitro. Although prednisolone and GH reverse hypoglycemia by different mechanisms, with only prednisolone suppressing tumor IGF-II secretion, both increase the formation of ternary IGF-IGFBP-3 complexes. We conclude that the failure of serum IGFBP-3 and tumor IGF- II to complex with ALS is a primary cause of hypoglycemia in nonislet cell tumor hypoglycemia.

This article has been cited by other articles:

				J. W. B de Groot, B. Rikhof, J. van Doorn, H. J G Bilo, M. A Alleman, A. H Honkoop, and W. T A van der Graaf Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases Endocr. Relat. Cancer, December 1, 2007; 14(4): 979 - 993. [Abstract] [Full Text] [PDF]

				M. A. Nauck, M. Reinecke, A. Perren, J. Frystyk, G. Berishvili, C. Zwimpfer, A. M. Figge, A. Flyvbjerg, P. G. Lankisch, W. F. Blum, et al. Hypoglycemia due to Paraneoplastic Secretion of Insulin-Like Growth Factor-I in a Patient with Metastasizing Large-Cell Carcinoma of the Lung J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1600 - 1605. [Abstract] [Full Text] [PDF]

				M. E Street, M. A Ziveri, C. Spaggiari, I. Viani, C. Volta, G. L. Grzincich, R. Virdis, and S. Bernasconi Inflammation is a modulator of the insulin-like growth factor (IGF)/IGF-binding protein system inducing reduced bioactivity of IGFs in cystic fibrosis Eur. J. Endocrinol., January 1, 2006; 154(1): 47 - 52. [Abstract] [Full Text] [PDF]

				R. C.W. Ma, P. C.Y. Tong, J. C.N. Chan, C. S. Cockram, and M. H.M. Chan A 67-year-old woman with recurrent hypoglycemia: non-islet cell tumour hypoglycemia Can. Med. Assoc. J., August 16, 2005; 173(4): 359 - 361. [Full Text] [PDF]

				F. Miraki-Moud, A. B. Grossman, M. Besser, J. P. Monson, and C. Camacho-Hubner A Rapid Method for Analyzing Serum Pro-Insulin-Like Growth Factor-II in Patients with Non-Islet Cell Tumor Hypoglycemia J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3819 - 3823. [Abstract] [Full Text] [PDF]

				S. Baron-Hay, F. Boyle, A. Ferrier, and C. Scott Elevated Serum Insulin-Like Growth Factor Binding Protein-2 as a Prognostic Marker in Patients with Ovarian Cancer Clin. Cancer Res., March 1, 2004; 10(5): 1796 - 1806. [Abstract] [Full Text] [PDF]

				S Ford-Dunn, A Smith, and N Sykes Tumour-induced hypoglycaemia Palliative Medicine, June 1, 2002; 16(4): 357 - 358. [PDF]

				An elderly man with pleural effusion and abnormal behaviour Postgrad. Med. J., June 1, 2001; 77(908): 412a - 412. [Full Text]

				O. Rena, P. L. Filosso, E. Papalia, M. Molinatti, P. Di Marzio, G. Maggi, and A. Oliaro Solitary fibrous tumour of the pleura: surgical treatment Eur. J. Cardiothorac. Surg., February 1, 2001; 19(2): 185 - 189. [Abstract] [Full Text] [PDF]

				P. J. D. Delhanty, C. D. Scott, S. Babu, and R. C. Baxter Acid-labile subunit regulation during the early stages of liver regeneration: implications for glucoregulation Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E287 - E295. [Abstract] [Full Text] [PDF]

				G. Van den Berghe, R. C. Baxter, F. Weekers, P. Wouters, C. Y. Bowers, and J. D. Veldhuis A Paradoxical Gender Dissociation within the Growth Hormone/Insulin-Like Growth Factor I Axis during Protracted Critical Illness J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 183 - 192. [Abstract] [Full Text]

				J. D. Urschel, T. M. Anderson, and B. P. Whooley Finger Clubbing and a Lung Mass Chest, June 1, 1999; 115(6): 1735 - 1737. [Full Text] [PDF]

				D. Gullo, L. Sciacca, G. Parrinello, L. Tomaselli, and R. Vigneri Treatment of Hemangiopericytoma-Induced Hypoglycemia with Growth Hormone and Corticosteroids J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1758 - 1759. [Full Text]

				N. Hizuka, I. Fukuda, K. Takano, K. Asakawa-Yasumoto, Y. Okubo, and H. Demura Serum High Molecular Weight Form of Insulin-Like Growth Factor II from Patients with Non-Islet Cell Tumor Hypoglycemia Is O-Glycosylated J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2875 - 2877. [Abstract] [Full Text]

				S. Rajaram, D. J. Baylink, and S. Mohan Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions Endocr. Rev., December 1, 1997; 18(6): 801 - 831. [Abstract] [Full Text]

				R. C. Baxter The Binding Protein's Binding Protein-- Clinical Applications of Acid-Labile Subunit (ALS) Measurement J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3941 - 3943. [Full Text] [PDF]

				I. Ueki, G. T. Ooi, M. L. Tremblay, K. R. Hurst, L. A. Bach, and Y. R. Boisclair Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system PNAS, June 6, 2000; 97(12): 6868 - 6873. [Abstract] [Full Text] [PDF]